Skip to Content

Crixivan

Licence status
Withdrawn: 26/03/2021
Active substances
Indinavir sulfate
Dosage Form
Capsule
Licence number
EU/1/96/024/003
Licence holder
Merck Sharp & Dohme BV

Licence information

ATC code
J05AE Protease inhibitors, J05AE02 indinavir
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2).
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
04/10/1996